Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction.
Statins are widely used drugs for the treatment of hypercholesterolaemia. A number of recent studies have suggested that statins also have pleiotropic effects on immune responses and statins have proven to be effective in the treatment of autoimmune diseases in animal models. Foxp3(+) T regulatory cells are a unique subset of CD4(+) T cells that mediate immunosuppression. Foxp3(+) T cells develop in the thymus, but can also be induced in peripheral sites in the presence of transforming growth factor-beta (TGF-beta). We demonstrate here that simvastatin blockade of the mevalonate pathway can mediate induction of mouse Foxp3(+) T cells and that simvastatin can synergize with low levels of TGF-beta to induce Foxp3(+) T cells. The effects of simvastatin are secondary to a blockade of protein geranylgeranylation, are mediated at late time-points after T-cell activation, and are associated with demethylation of the Foxp3 promoter. One major effect of simvastatin was inhibition of the induction of Smad6 and Smad7, inhibitory Smads that inhibit TGF-beta signalling. Our results suggest that one mechanism responsible for the immunosuppressive effects of statins is the ability to promote the generation of Foxp3(+) T regulatory cells.
Kim
Yong Chan
YC
Cellular Immunology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Kim
Kee Kwang
KK
Shevach
Ethan M
EM
D000818:Animals; D002478:Cells, Cultured; D019175:DNA Methylation; D051858:Forkhead Transcription Factors / Q000235:genetics / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic; D015398:Signal Transduction / Q000187:drug effects*; D019821:Simvastatin / Q000494:pharmacology*; D051905:Smad6 Protein / Q000276:immunology / Q000378:metabolism; D051906:Smad7 Protein / Q000276:immunology / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology* / Q000378:metabolism; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta / Q000276:immunology* / Q000378:metabolism
D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; D051905:Smad6 Protein; C497803:Smad6 protein, mouse; D051906:Smad7 Protein; C497807:Smad7 protein, mouse; D016212:Transforming Growth Factor beta; D019821:Simvastatin
J Immunol. 2004 May 1;172(9):5149-53
15100250
Eur J Immunol. 2008 Jun;38(6):1654-63
18493985
Nat Med. 2006 Feb;12(2):178-80
16462800
Nat Immunol. 2003 Apr;4(4):330-6
12612578
Blood. 2007 Dec 15;110(13):4588-98
17827390
Transplantation. 2005 Feb 15;79(3):372-4
15699774
J Biol Chem. 2009 May 29;284(22):14734-43
19332549
J Immunol. 2007 Apr 1;178(7):4022-6
17371955
Nat Med. 2001 Jun;7(6):687-92
11385505
Immunity. 2006 Aug;25(2):195-201
16920638
PLoS One. 2007 Aug 22;2(8):e779
17712427
Science. 2003 Feb 14;299(5609):1057-61
12522256
J Exp Med. 2007 Jul 9;204(7):1543-51
17591856
J Exp Med. 2006 Feb 20;203(2):401-12
16476765
Nature. 2002 Nov 7;420(6911):78-84
12422218
Int Immunol. 2009 Jun;21(6):679-89
19380384
Atherosclerosis. 2008 Apr;197(2):829-39
17826781
PLoS Biol. 2007 Feb;5(2):e38
17298177
Nat Immunol. 2008 Feb;9(2):194-202
18157133
J Immunol. 2008 May 15;180(10):6988-96
18453621
J Exp Med. 2003 Dec 15;198(12):1875-86
14676299
Immunity. 2006 Sep;25(3):441-54
16973387